Methods of and compositions for treating obesity, obesity-related diseases or cancers using a n6-methyllysine/l-lysine mixture
AssigneeTainnovation Inc.
InventorsJhen-Wei Ruan, Chih-Cheng Tai, Cheng-Yuan Kao
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to utilizing the N6-methyllysine for reducing fat percentage in an organ or tissue or for treating obesity, obesity-related diseases or cancers. More specifically, the present invention relates to the method using Nε-Methyl-L-lysine or Nε-Methyl-L-lysine producing bacteria or Nε-Methyl-L-lysine/l-lysine mixture or Nε-Methyl-L-lysine/probiotics mixture to treat obesity, obesity-related diseases or cancers.
Claims18
A method for treating obesity, or obesity-related diseases comprising:
- a. diagnosing a subject in need of treatment for obesity, an obesity-related disease;
- and
- b. increasing an amount of Nε-Methyl-L-lysine in the subject by administering an effective amount of Nε-Methyl-L-lysine or Nε-Methyl-L-lysine hydrochloride based on the diagnosing to reduce a body mass index or a percentage of fat in a predetermined organ.
(canceled)
(canceled)
(canceled)
(canceled)
A method of reducing a fat percentage in an organ or a body comprising:
- a) altering a microbiota composition in the subject's gastrointestinal tract by administering an effective amount of Nε-Methyl-L-lysine, or Nε-Methyl-L-lysine hydrochloride;
- and
- b) maintaining an effective concentration of the Nε-Methyl-L-lysine or the Nε-Methyl-L-lysine hydrochloride in the subject's serum to reduce a fat percentage in the organ or the body.
9-12. (canceled)
(canceled)
A dietary supplement formulation comprising:
- a) a mixture of one or more active ingredients and one or more fillers, wherein the one or more active ingredients contain at least 105 CFU of a Nε-Methyl-L-lysine, Nε-Methyl-L-lysine hydrochloride, or Nε-Methyl-L-lysine producing bacteria;
- and
- b) a package enclosing the mixture.
Dependencies are inferred from the claim text.